Biopharmaceutical Company with Innovative Cancer Therapeutics in Clinical Trials

Hilco is seeking offers for the business and assets of a biopharmaceutical company developing innovative drug candidates to address oncology and haematology indications.

Expressions of interest are due by 13 December.

Further details here.